Hiroshi Matsuda, T. Uehara, H. Okazawa, S. Mizumura, K. Yokoyama, M. Yoshimura
{"title":"第40次放射性药品不良反应调查报告(2017年第43次调查)。","authors":"Hiroshi Matsuda, T. Uehara, H. Okazawa, S. Mizumura, K. Yokoyama, M. Yoshimura","doi":"10.18893/kakuigaku.rp.1974","DOIUrl":null,"url":null,"abstract":"This survey was performed to investigate the incidence of adverse reactions to radiopharmaceuticals in FY2017 in Japan. It was based on the responses to questionnaires sent to nuclear medicine institutions. The reply was obtained from 981 institutions among 1,231 to which the questionnaire had been sent. Twelve cases of adverse reactions were reported. A total of 1,028,886 radiopharmaceutical administrations were reported. The incidence of adverse reactions per 100,000 cases was 1.2. No case of deficient products was reported.","PeriodicalId":17738,"journal":{"name":"Kaku igaku. The Japanese journal of nuclear medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"[The 40th Report on Survey of the Adverse Reaction to Radiopharmaceuticals (The 43rd Survey in 2017)].\",\"authors\":\"Hiroshi Matsuda, T. Uehara, H. Okazawa, S. Mizumura, K. Yokoyama, M. Yoshimura\",\"doi\":\"10.18893/kakuigaku.rp.1974\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This survey was performed to investigate the incidence of adverse reactions to radiopharmaceuticals in FY2017 in Japan. It was based on the responses to questionnaires sent to nuclear medicine institutions. The reply was obtained from 981 institutions among 1,231 to which the questionnaire had been sent. Twelve cases of adverse reactions were reported. A total of 1,028,886 radiopharmaceutical administrations were reported. The incidence of adverse reactions per 100,000 cases was 1.2. No case of deficient products was reported.\",\"PeriodicalId\":17738,\"journal\":{\"name\":\"Kaku igaku. The Japanese journal of nuclear medicine\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Kaku igaku. The Japanese journal of nuclear medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18893/kakuigaku.rp.1974\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kaku igaku. The Japanese journal of nuclear medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18893/kakuigaku.rp.1974","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
[The 40th Report on Survey of the Adverse Reaction to Radiopharmaceuticals (The 43rd Survey in 2017)].
This survey was performed to investigate the incidence of adverse reactions to radiopharmaceuticals in FY2017 in Japan. It was based on the responses to questionnaires sent to nuclear medicine institutions. The reply was obtained from 981 institutions among 1,231 to which the questionnaire had been sent. Twelve cases of adverse reactions were reported. A total of 1,028,886 radiopharmaceutical administrations were reported. The incidence of adverse reactions per 100,000 cases was 1.2. No case of deficient products was reported.
期刊介绍:
The main scope of JSNM is the appropriate development of the application of radioactive substances and stable nuclides in medicine. Towards this scope, JSNM promotes the exchange of idea and information, and researches in nuclear medicine. JSNM are interested in the international collaboration for the development of nuclear medicine. Through the activities, JSNM contributes to the medicine, as well as humanity, not only in Japan but also in any countries over the world.